Novartis (Thailand) Limited
Awards and Recognition:
2020
2021
2022
Company details
Address
689 Bhiraj Tower at EmQuartier 25th Fl.
Sukhumvit Road, North Klongton,
Vadhana District, Bangkok 10110
689 Bhiraj Tower at EmQuartier 25th Fl. Sukhumvit Road,
North Klongton, Vadhana District, Bangkok 10110
Industry
Pharmaceuticals
Vision
To be a trusted leader in changing
the practice of medicine.
To be a trusted leader in changing the practice of medicine.
Head Count
420
Website
Explore opportunities with us!
Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies shared a common goal of developing and marketing new products that contribute to human progress through advances in science and health. Building on this heritage, today, Novartis focuses its innovation prowess on addressing the unmet needs of patients worldwide.
Novartis (Thailand) ltd. employs over 400 associates in Thailand, bringing life changing medicines to Thai patients to tackle health challenges and improve quality of life.
Novartis (Thailand) ltd. employs over 400 associates in Thailand, bringing life changing medicines to Thai patients to tackle health challenges and improve quality of life.
Innovative Medicines & Sandoz Divisions
Innovative Medicines:The Innovative Medicines (IM) Division includes the Novartis Oncology and Novartis Pharmaceuticals business units. We are uniquely diversified across therapy areas including Cardiovascular& Immunology, Solid Tumor & Hematology, Neuroscience, and established medicines. Through our cutting-edge technology platforms, we reimagine medicine to improve and extend people's lives.
Sandoz:
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our global portfolio comprises approximately 1,000 molecules, covering all major therapeutic areas. Our products reach more than 500 million patients.
People & Culture
One of our key priorities is to “unleash the power of our people” which will help us fulfill our company's purpose of reimagining medicine to improve people’s lives. We cultivate a workplace where associates feel connected and empowered to perform their tasks with their fullest potential.With our cultural aspiration, we believe we can drive innovation, performance, and reputation through positive work experiences. At Novartis, we want to ensure that associates feel inspired by our purpose and constantly generate new ideas that can improve health outcomes. Additionally, we strive to create an “unbossed” culture in which leaders are encouraged to serve their teams, remove obstacles, and empower people to attain their personal and professional ambitions.
Novartis Thailand is truly honored to receive the HR Asia Best Companies to Work for award for the third consecutive year. This recognition reflects solid foundation we have built to foster diversity and inclusivity which drives our business success. It is our commitment to build a new generation of leaders with our culture of inspired, curious and unbossed. As the pandemic has revolutionized the way we work, we will continue investing in our associates as they are our greatest assets.
Sumalee Kristarnin, Country President
Creating an 'Unbossed' Environment in Novartis
To support this aspiration, our goal is to attract, develop and promote highly talented people who embodies the new culture, and to build a diverse and inclusive workforce with vast array of skills, experiences, and backgrounds.Diversity and inclusion: We treat our associates fairly, equally, and respectfully. For example, we provide our associates with 98-days paid parental leave for both parents. This includes the support for marriage, newborn baby, and baby delivery assistance. In addition, we also extend the Religious Observance Leave for 15 days for everyone regardless of their religion.
Transformation of Flexibility: We implemented ‘Choice with Responsibility’ policy which allows the associates to take full responsibility and accountability with their role and have more choice about how, when and where they work, as well as the responsibility to keep managers informed and align with teammates and stakeholders to ensure high-impact collaboration.
Well-being programs: We offer Energized for Life initiatives, including programs to improve employees’ health and well-being from physical to mental wellness. For example, we provide mental health support program to employees and their family members, an “Energized for Life Benefits” to support the expenses on associates’ health and wellness including their family members and life partners regardless of gender.
Reimagined Performance Management: Constructive dialogue between the associate and supervisor is an essential part of the Novartis Performance Management Process which considers both achievement on objectives and the Novartis Values and Behaviors.
Equal access to learning & Development: We create opportunities for our associates to take ownership of their growth by democratizing learning and development across all areas of Novartis. To do so, we are using the power of Artificial Intelligence to personalize career and learning opportunities and allow our associates to actively drive their development.
Putting Patient First
For over 50 years, Novartis, Thailand has committed to be a trusted partner with Thai healthcare and society. We work alongside stakeholders, including HCPs and the patient community, to address unmet medical needs. We passionately support patient empowerment, helping them to acquire sufficient knowledge so that they can advocate and share their voice to gain access to innovative treatments.To ensure no disruption in patient engagement during the outbreak of COVID-19, we adopted digital technologies to engage with patients, caregivers, and HCPs. We have organized disease awareness webinars and digital educational platforms for range of diseases such as Metastasis Breast Cancer and Blood cancer diseases such as Myeloproliferative neoplasms (MPNs) to enable patients to gain insight into diseases, thus ensuring that patients can fully participate in dialogue and share their needs.
